info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
Home » Healthcare » Angioplasty Balloons Market - Trend Analysis & Forecast

Angioplasty Balloons Market By Product Type (Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon), By Application (Coronary, Peripheral), By End-user (Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories), By Geography, Size, Trends, Industry Growth Report, Forecast, 2021-2030

Published On: May-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 40189351

Industry Report and Statistics (Facts & Figures) - Sales Volume, Procedure Conducted & ASP by Product, Application & End-User

The global angioplasty balloons market will witness a robust CAGR of 4.10%, valued at $2.60 billion in 2021, expected to appreciate and reach $3.73 billion by 2030, confirms Strategic Market Research. North America significantly held the maximum share of the market in 2020, and it is expected to continue its sheer dominance throughout the forecasted period. Angioplasty, also termed balloon angioplasty & percutaneous transluminal angioplasty, is considered a MI (minimally invasive) endovascular procedure. It is used to widen narrowed or obstructed arteries or veins to treat arterial atherosclerosis. A balloon-tipped catheter is implemented in angioplasty to clear a blocked blood vessel and improve blood flow throughout the human body. The angioplasty technique is primarily performed in a cardiac attack. The Global Health and Wellness Report of 2018 confirmed that approximately 40% of the adult population in the United States had been diagnosed with cardiovascular disease. Also, according to the Foundation de France, one out of every three adults in France is at risk of developing cardiovascular disease. In France, around 130,000 heart attacks and 120,000 strokes occur each year, which in turn is increasing the demand for Angioplasty balloons globally, thereby driving its industry growth.

 

Angioplasty Balloons Market by Infographics

 

Market Drivers - Increasing Prevalence of Cardiovascular Diseases, Growing Geriatric Population & Technological Advancements

  • The growing preponderance of CVD, such as coronary artery disease(CAD), peripheral artery disease(PAD) & hypertension, is a significant driver for the angioplasty balloons market. According to WHO, 17.9 Mn deaths occur due to cardiovascular disease globally. According to the report by CDC, one patient dies every 33 seconds in the US from CVD. These CVDs often require angioplasty to open up blocked or narrowed blood vessels, leading to a growing demand for the angioplasty balloons market.

 

  • World Health Organization states that 1 in 6 people will be above the age of 60 by 2030. With age, the risk of cardiovascular diseases increases & the increase in the geriatric population will increase the demand for angioplasty. A study suggests that 82% of people who die of CAD are above 65. As the global population is aging, the need for the angioplasty balloons market is expected to rise.

 

  • As per the American College of Cardiology (ACC), 1.2 Mn angioplasties are performed yearly in the US. Advances in angioplasty balloon technology have developed more efficient and effective devices to minimize patient risks. These advancements include the introduction of drug-eluting balloons (DEBs) and scoring balloons, which improve the procedure’s success rate and reduce the risk of restenosis (re-narrowing of the blood vessel). Technological innovations like robot-assisted Percutaneous coronary intervention (PCI) angioplasty can potentially lower radiation exposure for operators and musculoskeletal problems. Patients benefit from more precise stent placement, more accurate calculations of lesion length, and lower radiation and contrast media delivery.

 

global angioplasty balloons market by share 2020-2030

Restraints - Low Awareness in Underdeveloped Countries

  • In developing nations, a lack of knowledge will hinder market expansion. In addition, the industry will likely face challenges due to the scarcity of experienced medical personnel, high surgical procedure costs, and a lack of favorable reimbursement policies in emerging and undeveloped nations. 

 

  • Furthermore, increased product recalls and clinical risks or consequences of surgical procedures may stifle the industry's growth.

 

Opportunities - Increasing Prevalence of Target Illnesses

  • One of the major reasons driving the market expansion is an increase in the prevalence of target diseases. According to the WHO (World Health Organization), cardiovascular diseases impact 485.6 million people worldwide, with 17.9 million deaths. This figure represents 35% of all fatalities worldwide. Furthermore, heart attacks account for 85 percent of all fatalities associated with cardiovascular disease. Also, increasing awareness of the minimally invasive surgical procedures, Balloon angioplasty success rate, the launch of innovative products, and the rising prevalence of coronary and peripheral artery diseases in developing countries are expected to cater to ample opportunities for industry growth in the future.

 

  • Furthermore, the rise in usage of drug-eluting stents and the untapped potential of emerging markets contribute to lucrative market growth opportunities.

angioplasty balloons market by application 2020-2030

Market Analysis Of Different Segments Covered in the Report

Based on the Product Type

  • Normal Balloons

  • Scoring Balloons

  • Drug-eluting balloons

  • Cutting balloon

 

Based on Application

  • Coronary 

  • Peripheral 

 

Based on End-user

  • Ambulatory Surgery Centres (ASCs)

  • Hospitals

  • Catheterization Laboratories 

 

Regional Coverage Analysis

North America

  • The U.S.

  • Canada

  • Mexico

  • Rest of North America

 

Europe

  • France

  • Germany

  • U.K

  • Spain

  • Italy

  • Rest of Europe

 

Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • Rest of APAC

 

LAMEA

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

angioplasty balloons market by end user 2020-2030

Product Type Analysis & Insights

By Product, the Angioplasty Balloons is categorized into normal balloons, scoring balloons, drug-eluting balloons & cutting balloon. The normal balloon segment dominates the angioplasty balloons market with a revenue share of 65% and is estimated to dominate the industry for the forecasted period. Normal balloons have high burst pressure (the maximum pressure the balloon can withstand before rupturing) and cost-effectiveness give rise to the usage of normal balloons in angioplasty. Drug-eluting balloons are the fastest-growing segment in the angioplasty balloons market, with a growing CAGR of 17%. Benefits like better patency, low risk, and better lesion targeting drive the DEB market in the angioplasty balloons market.

 

Application Analysis & Insights

Based on the application, the angioplasty balloons market is categorized into coronary and peripheral. The Coronary segment dominates the market with a revenue share of 60% and is growing with a CAGR of 4.9% and is poised to reach $1.91 billion by 2030. According to the CDC, coronary artery disease (CAD) impacts 18.2 Mn adult population in the US, making it the most prevalent category of heart disorder. This rise in CAD proliferates the demand for percutaneous transluminal coronary angioplasty (PTCA). PTCA offers lower morbidity, low cost & shorter convalescence with a succession rate of 90%.

The peripheral segment is the fastest-growing application in the angioplasty balloons market, with a CAGR of 8.7%. According to a study, globally, 200 million adults suffer from PAD. This rising prevalence of PAD is raising the demand for the peripheral angioplasty balloons market.

 

End-User Analysis & Insights

Based on the End-user, the Hospital segment is expected to have the largest industry share in 2020. Advanced healthcare infrastructure, rising availability of skilled healthcare professionals, and affordability drive this segment's supremacy. According to a report published by the Advanced Medical Technology Association (AdvaMed), India's move to cap the maximum prices of various cardiovascular surgical instruments has reduced angioplasty procedure costs in tier 1 by up to 18 percent.

 

Region Analysis & Insights

Based on region, North America dominates the angioplasty balloons market with a revenue share of 35%. Annually,1.4 million angioplasties are performed in the North American region. A growing number of cardiovascular diseases in the USA and an increasing geriatric population drive the angioplasty balloons market.

European region is the fastest-growing market for angioplasty balloons market. Cardiovascular diseases (CVD) account for the most number of deaths in the EU, 3.8 million annually. The exponential rise in CVD cases, growing healthcare expenditure & developments of non-invasive procedures drives the angioplasty balloons market.

 

Angioplasty Balloons Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 2.60 billion

The revenue forecast in 2030

USD 3.73 billion

Growth rate

CAGR of approximately 4.10%

The base year for estimation

2021

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product, By Application, By End-user, By Region

By Product

Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon

By Application

Coronary, Peripheral 

By End-user

Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories

By Region

Asia Pacific, North America, Europe, LAMEA

Country Scope

U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc.

Company Usability Profiles

Spectranetics Corp., Becton, Medtronic PLC, Boston Scientific Corporation; Cook Medical, Inc., Dickinson and Company (C. R. Bard, Inc.), Cardinal Health (Cordis), ENDOCOR GmbH, Johnson & Johnson, Abbott Laboratories, etc.

 

Angioplasty Balloons Market Competitive Landscape Analysis

The competitive landscape analysis provides information about the crucial competitors prevailing in the global environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc.

 

angioplasty balloons market by region 2020-2030

 

Recent Developments

  • On January 2023, The FDA approved the Stellarex 0.035” OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. The FDA has expanded the indications for use to include re-opening blood vessels within a previously placed stent. The balloon is coated with paclitaxel, which may prevent arteries from narrowing again. The FDA approved the balloon for reopening blocked arteries in the thigh & knee due to PAD. The balloon can also open, narrowing blood vessels within an already-placed stent. After 12 months of testing, Stellarex 0.035” OTW DCB opened 76.3% of arteries without using a stent, while when used within a stent, it opened 58.8% of the arteries. 

 

  • On February 2023, The FDA approved the Magic Touch Sirolimus Coated Balloon from Concept Medical as an investigational device exemption (IDE). The Magic Touch PTA uses Nanolute Technology to deliver Sirolimus particles to deep vessel wall layers. The IDE approval will allow Concept Medical to collect data on the catheter's safety and efficiency, potentially securing a future premarket approval for the product in the US. The Magic Touch PTA Sirolimus Coated Balloon has already received a CE mark and has been assessed in clinical studies outside the US. It is currently being evaluated in Europe for the BTK indication in two RCTs. The new Magic Touch PTA Sirolimus coated balloon is believed to maintain BTK artery patency for longer compared to the current gold standard of plain balloon angioplasty.

 

  • On December 2022, Boston Scientific bought a majority stake of 65% in Chinese medical technology firm Acotec Scientific for $523 million. Acotec Scientific develops medical instruments, including DCB & percutaneous transluminal angioplasty balloon catheters (PTA). The company has a DCB product portfolio with 5 therapeutic target areas such as neurology, cardiology, nephrology, andrology & vascular surgery.

 

  • On December 2022, GIE Medical launched 2 clinical trials in the US to investigate using ProTractX3 TTS Drug-Coated Balloon technology to treat oesophagal & bowel strictures. The first trial, PATENT-E, aims to assess the efficacy and safety of the DCB technology for treating benign oesophagal strictures. The study will compare the improvement in dysphagia symptoms without repeat intervention at six months and the treatment-related major adverse incidents rate within 30 days. The company claims that the ProTractX3 3-Stage TTS DCB is coated with paclitaxel, a chemotherapeutic agent. The trials are expected to impact patient care and quality of life.

Frequently Asked Question About This Report

The global angioplasty balloons market is expected to grow at a compound annual growth rate (CAGR) of 4.10% from 2021 to 2030 to reach USD 3.73 billion by 2030.

Balloon angioplasty is a procedure used to unblock blocked or constricted arteries. It entails placing a catheter with a balloon attached to an artery. The balloon is inflated where plaque deposits have blocked or restricted blood flow.

In Gruentzigs time, the first angioplasty balloons were manufactured of flexible PVC (polyvinyl chloride). Cross-linked polyethylene was employed in the next generation of balloon technology. Polyethene terephthalate (PET) or nylon are the most common materials used in the twenty-first century.

Balloon angioplasty surgery is a procedure in which interventional cardiologists open constricted arteries. They employ a catheter, which is a long, thin tube with a tiny balloon at the tip. They inflate the balloon (using an angioplasty balloon inflation device), flattening or compressing the plaque against the arterial wall at the obstruction site.

The key segments inculcated in the angioplasty balloons market are Product Type, Application, End-users, and Region.

The global angioplasty balloons market share was around USD 2.60 Billion 2021, and it is forecasted to grow at a CAGR of 4.10% from 2021 to 2030. As a result, the global angioplasty balloons market Forecast suggests reaching around USD 3.73 Billion by 2030.

The global angioplasty balloons market size was around $2.60 Billion in 2021 and is predicted to reach $3.73 Billion in 2030.

Sources

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000558

https://www.fondationdefrance.org/en/cardiovascular-disease

https://www.cdc.gov/heartdisease/facts.htm

https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf

https://www.dicardiology.com/content/stellarex-0035-otw-drug-coated-angioplasty-balloon-fda-approved

https://www.medicaldevice-network.com/news/fda-concept-medical-coated-balloon/

https://www.medicaldevice-network.com/news/boston-scientific-acotec-scientific/

https://www.medicaldevice-network.com/news/gie-medical-drug-coated-balloon/

https://www.nature.com/articles/s41569-021-00607-3

https://www.nhlbi.nih.gov/health/coronary-heart-disease

https://www.ncbi.nlm.nih.gov/books/NBK535417/

https://publichealth.jmir.org/2022/11/e34908

https://www.ncbi..nlm.nih.gov/pmc

https://journals.sagepub.com/doi/10.1177/1708538120953663?icid=int.sj-abstract.similar-articles.1

https://pubmed.ncbi.nlm.nih.gov/22833302/#:~:text=Postulated%20benefits%20to%20patients%20include,exposure%20and%20contrast%2Dmedia%20delivery.

https://www.medicalnewstoday.com/articles/327154

https://www.dicardiology.com/article/overview-angioplasty-balloon-technology-advances

https://timesofindia.indiatimes.com/city/chennai/drug-coated-balloons-better-than-stents-docs/articleshow/98645699.cms?from=mdr

https://memorialhermann.org/services/specialties/heart-and-vascular/healthy-living/education/heart-disease-and-age

https://www.who.int/news-room/fact-sheets/detail/ageing-and-health

https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1 https://www.cdc.gov/heartdisease/facts.htm

 

 

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1  Angioplasty Balloons Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1  Market Snapshot

       4.2  Regional  Analysis

              4.2.1      market, by region, 2021-2030 (USD Million)

       4.3  By Product  Analysis

              4.3.1      market, By Product, 2021-2030 (USD Million)

       4.4  By End-user  Analysis

              4.4.1      market, By End-user, 2021-2030 (USD Million)

       4.5  Application  Analysis

              4.5.1      market, By Application, 2021-2030 (USD Million)

       4.6  Value Chain Analysis

       4.7  Market Variable Analysis

              4.7.1      Market Drivers Analysis

              4.7.2      Market Restraints Analysis

       4.8  Environment Analysis Tool

              4.8.1      PEST analysis

              4.8.2      Porter’s analysis

       4.9 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Application Analysis

              5.11.1.   Trends in Application (2014-2020)

              5.11.2.   Trends in Application (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By Region, By Country)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturing Sites, Area Served, Product Product

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Product Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Normal Balloons

              7.3.1. Normal Balloons market, 2021-2030 (USD Million)

       7.4. Scoring Balloons

              7.4.1. Scoring Balloons market, 2021-2030 (USD Million)

       7.5. Drug-eluting balloons

              7.5.1. Drug-eluting balloons market, 2021-2030 (USD Million)

       7.6. Cutting balloon

              7.6.1. Cutting balloon market, 2021-2030 (USD Million)

8. Global Market: By Application Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Coronary

              8.3.1.     Coronary market, 2021-2030 (USD Million)

       8.4. Peripheral

              8.4.1.     Peripheral market, 2021-2030 (USD Million)

9. Global Market: By End-User Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Ambulatory Surgery Centres (ASCs)

              9.3.1.     Ambulatory Surgery Centres (ASCs) market, 2021-2030 (USD Million)

       9.4. Hospitals

              9.4.1.     Hospitals market, 2021-2030 (USD Million)

       9.5. Catheterization Laboratories

              9.5.1.     Catheterization Laboratories market, 2021-2030 (USD Million)

10. Global Market: Regional Outlook

       10.1 North America

              10.1.1.   North America  market, by By Product, 2021-2030 (USD Million)

              10.1.2.   North America  market, by By End-user, 2021-2030 (USD Million)

              10.1.3.   North America  market, by Application, 2021-2030 (USD Million)

              10.1.4.   North America  market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S. market, by By Product, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S. market, by By End-user, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S. market, by Application, 2021-2030 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.   Canada market, by By Product, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada market, by By End-user, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada market, by Application, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe market, by By Product, 2021-2030 (USD Million)

              10.2.2.   Europe market, by By End-user, 2021-2030 (USD Million)

              10.2.3.   Europe market, by Application, 2021-2030 (USD Million)

              10.2.4.   Europe market, by country, 2021-2030 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.   U.K. market, by By Product, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K. market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K. market, by Application, 2021-2030 (USD Million)

   10.2.4.2.           Germany

                     10.2.4.2.1.   Germany market, by By Product, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany market, by Application, 2021-2030 (USD Million)

   10.2.4.3.           France

                     10.2.4.3.1.   France market, by By Product, 2021-2030 (USD Million)

                     10.2.4.3.2.   France market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.3.3.   France market, by Application, 2021-2030 (USD Million)

    10.2.4.4.          Rest of Europe

                     10.2.4.4.1.   Rest of Europe market, by By Product, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe market, by By End-user, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe market, by Application, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific market, by By Product, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific market, by By End-user, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific market, by Application, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific market, by country, 2021-2030 (USD Million)

   10.3.4.1.           China

                     10.3.4.1.1.   China market, by By Product, 2021-2030 (USD Million)

                     10.3.4.1.2.   China market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.1.3.   China market, by Application, 2021-2030 (USD Million)

   10.3.4.2.           India

                     10.3.4.2.1.   India market, by By Product, 2021-2030 (USD Million)

                     10.3.4.2.2.   India market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.2.3.   India market, by Application, 2021-2030 (USD Million)

   10.3.4.3.           Japan

                     10.3.4.3.1.   Japan market, by By Product, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan market, by Application, 2021-2030 (USD Million)

   10.3.4.4.           South Korea

                     10.3.4.4.1.   South Korea market, by By Product, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea market, by Application, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC market, by By End-user, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America market, by By Product, 2021-2030 (USD Million)

              10.4.2.   Latin America market, by By End-user, 2021-2030 (USD Million)

              10.4.3.   Latin America market, by Application, 2021-2030 (USD Million)

              10.4.4.   Latin America market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil market, by By Product, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil market, by Application, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico market, by By Product, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico market, by Application, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of the Latin America

                     10.4.4.3.1.   Rest of the Latin America market, by By Product, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America market, by By End-user, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America market, by Application, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA market, by By Product, 2021-2030 (USD Million)

              10.5.2.   MEA market, by By End-user, 2021-2030 (USD Million)

              10.5.3.   MEA market, by Application, 2021-2030 (USD Million)

              10.5.4.   MEA market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

       11.1 Boston Scientific Corporation

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Strategy & Recent Development

       11.2. Medtronic PLC

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Strategy & Recent Development

       11.3. Spectranetics Corp

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Strategy & Recent Development

       11.4. Becton, Dickinson and Company

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Strategy & Recent Development

       11.5. Abbott Laboratories

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Strategy & Recent Development

       11.6. Cook Medical, Inc

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Strategy & Recent Development

       11.7. Cardinal Health

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Strategy & Recent Development

       11.8. ENDOCOR GmbH

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Strategy & Recent Development

       11.9. Johnson & Johnson

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Strategy & Recent Development

       11.10. SINOMED

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Strategy & Recent Development

       11.11. Biotronik

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Strategy & Recent Development

 

 

List of Tables (51 Tables)

TABLE 1.  MARKET, By Product, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Normal Balloons, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Scoring Balloons, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Drug-eluting balloons, BY REGION, 2021-2030 (USD Million)

TABLE 5.  MARKET FOR Cutting balloon, BY REGION, 2021-2030 (USD Million)

TABLE 6. MARKET, By End-user, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Ambulatory Surgery Centres (ASCs), BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million)

TABLE 9. MARKET FOR Catheterization Laboratories, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 11. MARKET FOR Coronary, BY REGION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Peripheral, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 14. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 15. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million)

TABLE 16. NORTH AMERICA MARKET, By End-user, 2021-2030 (USD Million)

TABLE 17. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. EUROPE MARKET, By Product, 2021-2030 (USD Million)

TABLE 20. EUROPE MARKET, By End-user, 2021-2030 (USD Million)

TABLE 21. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 22. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million)

TABLE 24. ASIA-PACIFIC MARKET, By End-user, 2021-2030 (USD Million)

TABLE 25. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 26. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. LAMEA MARKET, By Product, 2021-2030 (USD Million)

TABLE 28. LAMEA MARKET, By End-user, 2021-2030 (USD Million)

TABLE 29. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 30. Boston Scientific Corporation: COMPANY SNAPSHOT

TABLE 31. Boston Scientific Corporation: OPERATING SEGMENTS

TABLE 32. Medtronic PLC: COMPANY SNAPSHOT

TABLE 33. Medtronic PLC: OPERATING SEGMENTS

TABLE 34. Spectranetics Corp: COMPANY SNAPSHOT

TABLE 35. Spectranetics Corp: OPERATING SEGMENTS

TABLE 36. Becton, Dickinson and Company : COMPANY SNAPSHOT

TABLE 37. Becton, Dickinson and Company: OPERATING SEGMENTS

TABLE 38. Abbott Laboratories: COMPANY SNAPSHOT

TABLE 39. Abbott Laboratories: OPERATING SEGMENTS

TABLE 40. Cook Medical, Inc: COMPANY SNAPSHOT

TABLE 41. Cook Medical, Inc: OPERATING SEGMENTS

TABLE 42. Cardinal Health: COMPANY SNAPSHOT

TABLE 43. Cardinal Health: OPERATING SEGMENTS

TABLE 44. ENDOCOR GmbH: COMPANY SNAPSHOT

TABLE 45. ENDOCOR GmbH: OPERATING SEGMENTS

TABLE 46. Johnson & Johnson: COMPANY SNAPSHOT

TABLE 47. Johnson & Johnson: OPERATING SEGMENTS

TABLE 48. SINOMED: COMPANY SNAPSHOT

TABLE 49. SINOMED: OPERATING SEGMENTS

TABLE 50. Biotronik: COMPANY SNAPSHOT

TABLE 51. Biotronik: OPERATING SEGMENTS

 

 

List of Figures (22 Figures)

Figure 1 Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Product-Based Estimation

Figure 6 Top 11 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Angioplasty Balloons, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-user, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Drug-eluting balloons to Witness Higher CAGR in Market for Product Segment during Forecast Period.

Figure 16 Peripheral to Witness Higher CAGR in Market for Application Segment during Forecast Period.

Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Segment during Forecast Period.

Figure 18 Asia Pacific region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America: Market Snapshot

Figure 21 Asia Pacific: Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview